{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:01:19Z","timestamp":1787504479915,"version":"build-2736575974"},"reference-count":21,"publisher":"Baskent University","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2020,8,10]]},"DOI":"10.6002\/ect.2019.0297","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T03:10:30Z","timestamp":1594177830000},"page":"481-484","source":"Crossref","is-referenced-by-count":5,"title":["Liver Transplant Due to Flupirtine-Induced Acute Liver Failure"],"prefix":"10.6002","volume":"18","author":[{"given":"Felix","family":"Dondorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland S.","family":"Croner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Tautenhahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Felgendreff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ardelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utz","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Rauchfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf. 2013;36(2):135-144. doi:10.1007\/s40264-012-0013-7","DOI":"10.1007\/s40264-012-0013-7"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190-201. doi:10.1016\/S0140-6736(10)60274-7","DOI":"10.1016\/S0140-6736(10)60274-7"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Douros A, Bronder E, Andersohn F, et al. Flupirtine-induced liver injury: seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol. 2014;70(4):453-459. doi:10.1007\/s00228-013-1631-4","DOI":"10.1007\/s00228-013-1631-4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dorr J, Wernecke KD, Wurfel J, et al. Disease modification in multiple sclerosis by flupirtine-results of a randomized placebo controlled phase II trial. Front Neurol. 2018;9:842. doi:10.3389\/fneur.2018.00842","DOI":"10.3389\/fneur.2018.00842"},{"key":"ref4","unstructured":"5. Klein F, Glanemann M, Rudolph B, Seehofer D, Neuhaus P. Flupirtine-induced hepatic failure requiring orthotopic liver transplant. Exp Clin Transplant. 2011;9(4):270-272."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Borlak J, van Bommel F, Berg T. N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury. Liver Int. 2018;38(2):365-376. doi:10.1111\/liv.13538","DOI":"10.1111\/liv.13538"},{"key":"ref6","unstructured":"7. Federal Institute for Drugs and Medical Devices. [Rote-Hand-Brief on flupirtine drugs: risk of liver toxicity]. July 16, 2013. Accessed June 10, 2020. https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2013\/rhb-flupirtin.html"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Biolato M, Araneo C, Marrone G, et al. Liver transplantation for drug-induced acute liver failure. Eur Rev Med Pharmacol Sci. 2017;21(1 Suppl):37-45.","DOI":"10.1016\/j.cld.2016.08.003"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Devarbhavi H, Patil M, Reddy VV, Singh R, Joseph T, Ganga D. Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients. Liver Int. 2018;38(7):1322-1329. doi:10.1111\/liv.13662","DOI":"10.1111\/liv.13662"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57(2):288-296. doi:10.1016\/j.jhep.2012.03.017","DOI":"10.1016\/j.jhep.2012.03.017"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011;108(42):714-720. doi:10.3238\/arztebl.2011.0714","DOI":"10.3238\/arztebl.2011.0714"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Puls F, Agne C, Klein F, et al. Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases. Virchows Arch. 2011;458(6):709-716. doi:10.1007\/s00428-011-1087-9","DOI":"10.1007\/s00428-011-1087-9"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Ndekwe P, Ghabril MS, Zang Y, Mann SA, Cummings OW, Lin J. Substantial hepatic necrosis is prognostic in fulminant liver failure. World J Gastroenterol. 2017;23(23):4303-4310. doi:10.3748\/wjg.v23.i23.4303","DOI":"10.3748\/wjg.v23.i23.4303"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Harish S, Bhuvana K, Bengalorkar GM, Kumar T. Flupirtine: clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012;28(2):172-177. doi:10.4103\/0970-9185.94833","DOI":"10.4103\/0970-9185.94833"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Michel MC, Radziszewski P, Falconer C, Marschall-Kehrel D, Blot K. Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years. Br J Clin Pharmacol. 2012;73(5):821-825. doi:10.1111\/j.1365-2125.2011.04138.x","DOI":"10.1111\/j.1365-2125.2011.04138.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Klawe C, Maschke M. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opin Pharmacother. 2009;10(9):1495-1500. doi:10.1517\/14656560902988528","DOI":"10.1517\/14656560902988528"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Konishi K, Fukami T, Ogiso T, Nakajima M. In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injury. Biochem Pharmacol. 2018;155:242-251. doi:10.1016\/j.bcp.2018.07.019","DOI":"10.1016\/j.bcp.2018.07.019"},{"key":"ref17","unstructured":"18. Kreutzkamp B. [Flupirtine helps - but pay attention to the liver!]. Med Monatsschr Pharm. 2015;38(4):149-150."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Anderson N, Borlak J. Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting. PLoS One. 2011;6(10):e25221. doi:10.1371\/journal.pone.0025221","DOI":"10.1371\/journal.pone.0025221"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Puljak L. Flupirtine, an effective analgesic, but hepatotoxicity should limit its use. Anesth Analg. 2018;127(1):309-310. doi:10.1213\/ANE.0000000000003355","DOI":"10.1213\/ANE.0000000000003355"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Lawson K. Flupirtine is an effective analgesic: is the associated rare liver injury a limiting factor to its use? Anesth Analg. 2018;127(2):e24-e25. doi:10.1213\/ANE.0000000000003436","DOI":"10.1213\/ANE.0000000000003436"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:43:37Z","timestamp":1597301017000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2020\/18\/4\/0\/481\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2019.0297","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}